Hepatic Arterial Infusion of Nab-Paclitaxel in Patients With Metastatic Melanoma in the Liver
Status:
Completed
Trial end date:
2014-11-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research is to find the highest tolerable dose of Abraxane
(nab-paclitaxel) when given directly to the area where the cancer is located. The safety of
this drug will also be studied.